Related Experiment Video
Updated: Apr 15, 2026
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Notch signaling: a hero or villain in the war against cancer?
Shireen Chikara1, Katie M Reindl1
1Department of Biological Sciences, North Dakota State University, Fargo, ND, 51808-6050, USA.
Abstract:
The Notch signal transduction pathway regulates cell fate decisions throughout embryonic development. The mechanisms through which Notch signaling maintains cellular integrity are well understood. However, Notch signaling is more complex than previously thought as Notch is also involved in cancer where it functions as both an oncogene and tumor suppressor depending on the cellular context. Aberrant activation of oncogenic Notch is found in various cancers prompting the search for therapeutic agents to attenuate constitutively active Notch. However, there is also substantial evidence that Notch signaling suppresses tumor growth and progression, suggesting that Notch activators might be of therapeutic benefit in other cancers. This editorial describes the dual role of Notch signaling observed within and across multiple cancers. We highlight a study in non-small cell lung cancer cells (NSCLC) revealing a tumor suppressive role for endothelial cell Dll4-activated Notch1 and the underlying molecular mechanism involving suppression of PI3K signaling.
Insights
Notch signaling has a dual role in cancer, acting as both an oncogene and tumor suppressor. A study in non-small cell lung cancer reveals Notch1 signaling suppresses tumor growth by inhibiting PI3K signaling.
Area of Science:
- Cellular biology
- Molecular oncology
- Cancer research
Background:
- The Notch signal transduction pathway is crucial for embryonic development and cellular integrity.
- Notch signaling exhibits context-dependent roles in cancer, functioning as both an oncogene and a tumor suppressor.
- Aberrant Notch activation is implicated in various cancers, driving therapeutic interest in Notch inhibitors.
Purpose of the Study:
- To explore the complex and dual role of Notch signaling in cancer.
- To highlight a specific study investigating Notch signaling in non-small cell lung cancer (NSCLC).
- To elucidate the molecular mechanisms underlying Notch's tumor-suppressive functions.
Main Methods:
- Review of existing literature on Notch signaling in cancer.
- Focus on a study examining endothelial cell Dll4-activated Notch1 in NSCLC.
- Analysis of the molecular pathways, including PI3K signaling, affected by Notch activation.
Main Results:
- Notch signaling demonstrates a dual role across various cancers, acting as an oncogene or tumor suppressor.
- Endothelial cell Dll4-activated Notch1 was found to have a tumor-suppressive role in NSCLC.
- This tumor suppression is mediated by the inhibition of PI3K signaling.
Conclusions:
- Notch signaling's role in cancer is complex and highly context-dependent.
- Targeting Notch activators may offer therapeutic benefits in specific cancer types, such as NSCLC.
- Understanding the molecular mechanisms, like PI3K inhibition, is key for developing targeted therapies.
Related Concept Videos
03:14Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
03:14Notch Signaling Pathway
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...